We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
The National Health and Medical Research Council’s (NHMRC) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Guideline Development Committee (ME/CFS GDC) held its inaugural meeting on Thursday 28 August 2025 to commence development of clinical practice guidelines for ME/CFS and related conditions, including Long COVID, postural orthostatic tachycardia syndrome (POTS) and fibromyalgia.
Date: Thursday 28 August 2025
Time: 12:30 pm – 2:30 pm AEST
Location: Virtual meeting
The ME/CFS GDC is established as a section 39 committee under the NHMRC Act 1992 and includes clinicians, researchers, individuals with lived experience and people with experience in reviewing evidence and developing guidelines. The ME/CFS GDC is tasked with overseeing the development of clinical practice guidelines for the diagnosis and management of ME/CFS and related conditions in primary care settings.
The next meeting of the ME/CFS GDC is planned for late October 2025 and will focus on gaining a shared understanding of the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methods approach.